Keyphrases
Antibody Level
28%
Antibody Response
14%
Antiretroviral Therapy
100%
Antiretroviral Therapy Initiation
14%
Bactericidal Assay
14%
Diphtheria Toxoid
71%
DTwP
14%
Early Antiretroviral Therapy
14%
ELISA Assay
14%
Exposure Therapy
100%
Filamentous Hemagglutinin
42%
Geometric Mean Concentration
42%
Haemophilus Influenzae Type b Vaccine
28%
Hemagglutinin 2
14%
Hepatitis B Surface Antigen (HBsAg)
57%
Hepatitis B Vaccine
42%
HIV Exposure
14%
HIV Infection
14%
HIV Patients
57%
HIV-exposed Infants
42%
HIV-infected children
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Immune Response
14%
Immunogenicity
100%
Luminex
14%
Maternal HIV Infection
14%
Monovalent Cations
14%
Multiplex Immunoassay
14%
Pertussis Toxin
14%
Pertussis Toxoid
14%
Pre-vaccination
14%
Preventive Vaccine
14%
Proportion Difference
14%
Revaccination
42%
Ribitol Phosphate
14%
Seroconversion Rate
14%
Specific Antibodies
14%
Tetanus Toxoid
85%
Treatment Strategy
100%
Uninfected Infants
14%
Vaccination
14%
Whole-cell Pertussis
14%
Immunology and Microbiology
Antibodies
10%
Antibody Response
10%
CD4
10%
Conjugate Vaccine
20%
Diphtheria Tetanus Toxoid
30%
Diphtheria Toxoid
20%
ELISA
10%
Haemophilus Influenzae Type B
20%
HBsAg
40%
Hemagglutinin
30%
Hepatitis B Antigen
40%
Hepatitis B Vaccine
30%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus Infection
10%
Immune Response
10%
Immunoassay
10%
Immunogenicity
100%
Immunology
40%
Infancy
100%
Pertussis Toxin
10%
Seroconversion
10%
Tetanus Vaccine
30%
Toxoid
40%
Whole Cell
10%